Y. Zhuang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Y. Zhuang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Y Zhang
Department of nephrology, General Hospital of PLA, Beijing 100853, China
2 shared publicationsC G Wang
1 shared publicationG Y Xu
1 shared publicationJ. Shi
Department of Urology, Tangshan Gongren Hospital, Hebei Medical University, No. 27, Wenhua Road, Lubei District, Tangshan, 063000, China
1 shared publicationJ.S. Olsen
Niels Bohr Institute, Oersted Laboratory, DK-2100 Copenhagen, Denmark
1 shared publication- Jian-Zhong Jiang
Zhejiang University
1 shared publication
Latest Publications
- 3 September 2014
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 16 (11) , 986-992
TGF-beta induced RBL2 expression in renal cancer cells by down-regulating miR-93
TGF-beta can induce G1 arrest via many mechanisms including up-regulating p21, p27, and Rb. However, as the member of Rb family, whether RBL2 is induced by TGF-beta treatment remains exclusive.
- 3 September 2014
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 16 (11) , 986-992
TGF-beta induced RBL2 expression in renal cancer cells by down-regulating miR-93
TGF-beta can induce G1 arrest via many mechanisms including up-regulating p21, p27, and Rb. However, as the member of Rb family, whether RBL2 is induced by TGF-beta treatment remains exclusive.
- 1 September 2001
- Vol. 40 (9) , 613-7
[Clinical analysis of tubulointerstitial lesions in IgA nephropathy].
To analyze the characteristics of tubulointerstitial lesions (TIL) in IgA nephropathy (IgAN). The pathologic and clinical materials of 609 IgAN patients were analyzed. (1) Prevalence characteristics of TIL: Among all the patients, these with mild TIL accounted for 47.1%, moderate TIL 21.7%, severe TIL was about 16.6% and these without TIL 14.6%. (2) Relationship between TIL and the clinical findings: With increase of the severity of TIL, hypertension became worse and the level of proteinuria increased gradually. On the contrary, serum albumin decreased and renal function degraded. (3) Relationship between TIL and the pathologic findings: With increase of the severity of TIL, the scores of vascular lesion, total glomerular lesion, hypercellularity and glomerulosclerosis increased gradually. Moreover, when the glomerular lesion and vascular lesion became worse, the severity of TIL also increased. The relationship with the crescents was different, the score of the presence of crescents was highest when TIL was moderate in severity; it would not increase when TIL was severe. With the increase of the severity of TIL, the condition of IgAN patients became worse. TIL may be one of the key factors for the prognosis of IgAN. TIL is closely related to the severity of glomerular and vascular lesions, and these lesions may further lead to the development of TIL.
- 1 September 2001
- Vol. 40 (9) , 613-7
[Clinical analysis of tubulointerstitial lesions in IgA nephropathy].
To analyze the characteristics of tubulointerstitial lesions (TIL) in IgA nephropathy (IgAN). The pathologic and clinical materials of 609 IgAN patients were analyzed. (1) Prevalence characteristics of TIL: Among all the patients, these with mild TIL accounted for 47.1%, moderate TIL 21.7%, severe TIL was about 16.6% and these without TIL 14.6%. (2) Relationship between TIL and the clinical findings: With increase of the severity of TIL, hypertension became worse and the level of proteinuria increased gradually. On the contrary, serum albumin decreased and renal function degraded. (3) Relationship between TIL and the pathologic findings: With increase of the severity of TIL, the scores of vascular lesion, total glomerular lesion, hypercellularity and glomerulosclerosis increased gradually. Moreover, when the glomerular lesion and vascular lesion became worse, the severity of TIL also increased. The relationship with the crescents was different, the score of the presence of crescents was highest when TIL was moderate in severity; it would not increase when TIL was severe. With the increase of the severity of TIL, the condition of IgAN patients became worse. TIL may be one of the key factors for the prognosis of IgAN. TIL is closely related to the severity of glomerular and vascular lesions, and these lesions may further lead to the development of TIL.
- 1 January 2000
- Published by Springer Nature in MRS Proceedings
- Vol. 644
Crystallization of Bulk Zr48Nb8Cu14Ni12Be18Metallic Glass
- 1 January 2000
- Published by Springer Nature in MRS Proceedings
- Vol. 644
Crystallization of Bulk Zr48Nb8Cu14Ni12Be18Metallic Glass
- 1 August 1998
- Vol. 33 (8) , 472-4
[Study on the karyotype and recurrence risk of malformed newborns].
To survey the karyotype and recurrence risk of malformed newborns. Karyotypes of 104 malformed newborns were analyzed using G-banding. All cases were devided into two groups depending on their karyotypes: Group 1 with normal karyotype (n = 51) and group 2 with abnormal (n = 53). Clinical data were compared between malformed groups and control. Women who had the second babies after delivering a malformed (n = 20) were included in the statistics of recurrence risk. (1) Of 104 cases, 53 had abnormal karyotype (50.96%). They were trisomy 21, trisomy 18, 45X, 1q+ and 5p+ (n = 41, 9, 1, 1, 1, seperately). (2) Within group 2, women's mean delivery age was elder, while premature delivery rate was higher than that of control (P < 0.01, 0.05). In group 1, the proportion of women with abnormal pregnancy history increased as compared with control (P < 0.05). The rate of fetal distress, poly/oligohydramnios and small for gestational age (SGA) of two malformed groups was higher apparently than that of control. The birth weight of two malformed groups declined obviously. (3) Within 20 second babies being born after their malformed siblings, 6 were malformed too. The total recurrence rate was 30%. (1) Abnormal karyotype is an important cause of congenital malformations; (2) The age pregnant women abnormal pregnancy history, IUGR and poly/oligohydramnios all may be the high risk factors of congenital malformations; (3) The recurrence rate of malformations rises after the first malformed newborn's birth.
- 1 August 1998
- Vol. 33 (8) , 472-4
[Study on the karyotype and recurrence risk of malformed newborns].
To survey the karyotype and recurrence risk of malformed newborns. Karyotypes of 104 malformed newborns were analyzed using G-banding. All cases were devided into two groups depending on their karyotypes: Group 1 with normal karyotype (n = 51) and group 2 with abnormal (n = 53). Clinical data were compared between malformed groups and control. Women who had the second babies after delivering a malformed (n = 20) were included in the statistics of recurrence risk. (1) Of 104 cases, 53 had abnormal karyotype (50.96%). They were trisomy 21, trisomy 18, 45X, 1q+ and 5p+ (n = 41, 9, 1, 1, 1, seperately). (2) Within group 2, women's mean delivery age was elder, while premature delivery rate was higher than that of control (P < 0.01, 0.05). In group 1, the proportion of women with abnormal pregnancy history increased as compared with control (P < 0.05). The rate of fetal distress, poly/oligohydramnios and small for gestational age (SGA) of two malformed groups was higher apparently than that of control. The birth weight of two malformed groups declined obviously. (3) Within 20 second babies being born after their malformed siblings, 6 were malformed too. The total recurrence rate was 30%. (1) Abnormal karyotype is an important cause of congenital malformations; (2) The age pregnant women abnormal pregnancy history, IUGR and poly/oligohydramnios all may be the high risk factors of congenital malformations; (3) The recurrence rate of malformations rises after the first malformed newborn's birth.
- 1 March 1982
- Vol. 17 (3) , 212-7
[Determination of O-methyldihydroartemisinine(artemether) in plasma by quantitative TLC scanning technique (author's transl)].
- 1 March 1982
- Vol. 17 (3) , 212-7
[Determination of O-methyldihydroartemisinine(artemether) in plasma by quantitative TLC scanning technique (author's transl)].